Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells-Reference-Cited by-同舟云学术

Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells

Published:2019-06-08 Issue:7 Volume:68 Page:1195-1209
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Gong Wenjie^ORCID,Hoffmann Jean-Marc,Stock Sophia,Wang Lei,Liu Yibin,Schubert Maria-Luisa,Neuber Brigitte,Hückelhoven-Krauss Angela,Gern Ulrike,Schmitt Anita,Müller-Tidow Carsten,Shiku Hiroshi,Schmitt Michael,Sellner Leopold

Funder

Government of Baden-Württemberg

Deutsches Konsortium für Translationale Krebsforschung

Deutsches Krebsforschungszentrum

Medizinischen Fakultät Heidelberg, Universität Heidelberg

NCT Heidelberg School of Oncology

the German Society of Internal Medicine

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-019-02354-4.pdf

Reference47 articles.

1. Rosenberg SA, Restifo NP (2015) Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348(6230):62–68. https://doi.org/10.1126/science.aaa4967

2. Kunert A, Straetemans T, Govers C, Lamers C, Mathijssen R, Sleijfer S, Debets R (2013) TCR-engineered T cells meet new challenges to treat solid tumors: choice of antigen, T cell fitness, and sensitization of tumor milieu. Front Immunol 4:363

3. Park TS, Groh EM, Patel K, Kerkar SP, Lee CC, Rosenberg SA (2016) Expression of MAGE-A and NY-ESO-1 in primary and metastatic cancers. J Immunother 39(1):1–7. https://doi.org/10.1097/cji.0000000000000101

4. Barrow C, Browning J, MacGregor D, Davis ID, Sturrock S, Jungbluth AA, Cebon J (2006) Tumor antigen expression in melanoma varies according to antigen and stage. Clin Cancer Res 12(3 Pt 1):764–771. https://doi.org/10.1158/1078-0432.Ccr-05-1544

5. Endo M, de Graaff MA, Ingram DR, Lim S, Lev DC, Briaire-de Bruijn IH, Somaiah N, Bovee JV, Lazar AJ, Nielsen TO (2015) NY-ESO-1 (CTAG1B) expression in mesenchymal tumors. Mod Pathol 28(4):587–595. https://doi.org/10.1038/modpathol.2014.155

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma;Cancer Immunology, Immunotherapy;2024-08-02

2. Current Strategies to Improve Chimeric Antigen Receptor T (CAR-T) Cell Persistence;Cureus;2024-07-24

3. Altered cancer metabolism and implications for next-generation CAR T-cell therapies;Pharmacology & Therapeutics;2024-07

4. Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development;International Journal of Molecular Sciences;2024-06-11

5. Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV‐1 neutralizing antibodies;Journal of Medical Virology;2024-06